Use of VAJRAKA GHRITA in the management of EKAKUSTHA

A Clinical study on the role of Vajrak Ghrita in Ekakustha W.S.R to Psoriasis - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071333

Enrollment

Registered

2024-07-25

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing to participate in clinical trial. Patient having clinical signs & symptoms of Ekakustha (Psoriasis). Patients having chronicity less than ten years duration.

Exclusion criteria

Exclusion criteria: Patient who are not willing to be included in the study. Chronicity more than ten years. Pregnant and Lactating women. Patients with Psoriatic arthropathy. Patients with uncontrolled DM and HTN. Patients with K/C/O severe heart diseases, kidney diseases, stroke, liver diseases. Patients with K/C/O severe systemic illness like R.A., Gout, S.L.E. etc. Patients with K/C/O pulmonary dysfunction or COPD Patients with history of any acute or chronic infectious diseases like TB, AIDS, Other STDs. Patients taking medications like corticosteroids, hormonal therapy, anti-depressants or any other drugs which may affect outcome of the study. Patients with alcohol addiction or drug abuse.

Design outcomes

Primary

Measure	Time frame
result will be assessed on the basis of improvement in subjective and objective sign and symptoms of psoriasis.Timepoint: 28 days	—

Secondary

Measure	Time frame
to imrove quality of lifeTimepoint: 14 Days	—

Countries

India

Contacts

Public ContactDr Dipti S Purani

Government akhandanand ayurved college and hospital

diptipandya73@yahoo.in9427794040

Outcome results